Search Results
Apr 20, 2026, 08:42 ET Evidence-Based: New MIT Study Validates Learning Ally's Audiobook Solution for K-12 Vocabulary Gains
clear evidence of the power of Learning Ally's Audiobook Solution to accelerate literacy development and improve vocabulary scores," said Howard Bell III, Chief Executive Officer of Learning Ally. "They also underscore what educators have long observed—that the tools are most effective when paired with
More news about: Learning Ally
Apr 20, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.976 Million Tokens, and Total Crypto and Total Cash Holdings of $12.9 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's CathieWood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital andpersonal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: Bitmine Immersion Technologies, Inc.
Apr 20, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.976 Million Tokens, and Total Crypto and Total Cash Holdings of $12.9 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's CathieWood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital andpersonal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: Bitmine Immersion Technologies, Inc.
Apr 20, 2026, 08:17 ET YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026
markets in Hong Kong and the broader Southeast Asian region, including Malaysia, Singapore, and Thailand, (ii) capital and credit market volatility, (iii) local and global economic conditions, (iv) our anticipated growth strategies, (v) governmental approvals and regulations, and (vi) our future business
More news about: YY Group Holding Limited
Apr 20, 2026, 08:02 ET Farmers Insurance® Encourages Tornado Preparedness as Severe Weather Impacts More Communities
Farmers.com, as well as helpful coverage information.Sources:1Insurance Information Institute (III or Triple‑I), 2025 Tornadoes Highlight Convective Storm Losses,
More news about: Farmers Insurance
Apr 20, 2026, 08:00 ET Sapience Therapeutics Presents First Clinical Results from Phase 2 Study of ST316, First-in-Class β-catenin Antagonist, in Second-Line Colorectal Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2026
β-catenin antagonist, demonstrates safety and efficacy in metastatic colorectal cancer (mCRC)"Session Title: Phase II and Phase III Clinical TrialsLocation: Poster Section 52, Poster Board Number 20Abstract Number: CT156Date and Time: Monday, April 20, 2026,
More news about: Sapience Therapeutics, Inc.
Apr 20, 2026, 07:41 ET EPG publica su primer informe ESG, estableciendo una base para la expansión global sostenible
mínimo. Creemos que la modularidad es la clave para lograrlo". EPG se enorgullece de haber contribuido al libro Greener Data, Volumen III, que se presentará el Día de la Tierra de 2026. El capítulo compartió la filosofía de EPG sobre cómo la construcción modular reduce los residuos en obra,
More news about: EPG Singapore Pte Ltd
Apr 20, 2026, 07:30 ET 52-Week Topline Results from 16-Week Blinded Treatment Extension of REZOLVE-AA Demonstrate Deepening of Responses in Severe-to-Very-Severe Alopecia Areata with Rezpegaldesleukin
including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422 are in clinical development and the risk of failure is high and can unexpectedly occur at any stage
More news about: Nektar Therapeutics
Apr 20, 2026, 07:00 ET Stanley Black & Decker Does Not Expect Recent Section 232 Tariff Changes To Impact 2026 Guidance Materially
availability and prices, inflation and deflation, interest rate volatility, currency exchange rates, and uncertainties in the global financial markets; (iii) laws, regulations and governmental policies affecting the Company's activities in the countries where it does business or sources supply inputs, including
More news about: Stanley Black & Decker, Inc.
Apr 20, 2026, 06:45 ET U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
(i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue
More news about: Astellas Pharma Inc.
Apr 20, 2026, 06:30 ET AGNICO EAGLE TO CONSOLIDATE FINLAND'S CENTRAL LAPLAND GREENSTONE BELT IN THREE SEPARATE TRANSACTIONS
Resources Ltd. ("Rupert"); (ii) the acquisition of all of the issued and outstanding shares of Aurion Resources Ltd. ("Aurion"); and (iii) the acquisition of a 70% interest in Fingold Ventures Ltd. (the "Fingold JV") held by B2Gold Corp. ("B2Gold"), which together with the
More news about: Agnico Eagle Mines Limited
Apr 20, 2026, 06:15 ET STLA INVESTOR NOTICE: Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
Stellantis' confidence in the electrification market or otherwise defendants' faith in Stellantis' ability to capitalize on such growth was misplaced; and (iii) Stellantis would ultimately see earnings slide through repeated guidance reductions despite efforts to minimize the potential of any impact until it
More news about: Robbins Geller Rudman & Dowd LLP
Apr 20, 2026, 06:07 ET Immunofoco Presents Preclinical Data for IMV102, an In Vivo CAR-T Candidate, Demonstrating Durable Tumor Control at the AACR 2026
survival benefits for patients suffering from cancer and autoimmune diseases. Its lead program, IMC002 (CLDN18.2 CAR-T), is currently in a pivotal Phase III trial in China.The company leverages a "dual-engine" growth model, advancing ex vivo CAR-T therapies for solid tumors and in vivo CAR-T therapies
More news about: Immunofoco
Apr 20, 2026, 06:00 ET Hyperscale Data Accelerates Michigan Operations Capabilities for AI Data Center and Robotics Hub
here.The webcast will feature:William B. Horne, Chief Executive Officer; andMilton "Todd" Ault III, Executive Chairman.Executive CommentaryWilliam B. Horne, Chief Executive Officer of Hyperscale Data, stated:"We are
More news about: Hyperscale Data Inc.
Apr 20, 2026, 04:00 ET Hyperscale Data Issues Strategic Statement by Its Executive Chairman on Omnipresent Robotics and U.S. Based Robotics Infrastructure and Embodied AI Development
("Hyperscale Data" or the "Company"), today released a statement issued by its Executive Chairman, Milton "Todd" Ault, III, on behalf of its wholly owned subsidiary
More news about: Hyperscale Data Inc.
Apr 20, 2026, 02:05 ET Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation - IMMP
this about: On March 13, 2026, Immutep issued a press release "announcing that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1(st) line non-small cell lung cancer has recommended the discontinuation of the trial following
More news about: THE ROSEN LAW FIRM, P. A.
Apr 19, 2026, 22:00 ET EPG Publishes Inaugural ESG Report, Establishing Baseline for Sustainable Global Expansion
carry light footprint. We believe modular is how the industry gets there."EPG is proud to have contributed to the book Greener Data, Volume III, launching on Earth Day 2026. The chapter shared EPG's philosophy on how modular construction reduces on-site waste, lowers embodied carbon, and enables
More news about: EPG Singapore Pte Ltd
Apr 19, 2026, 22:00 ET EPG Publishes Inaugural ESG Report, Establishing Baseline for Sustainable Global Expansion
carry light footprint. We believe modular is how the industry gets there."EPG is proud to have contributed to the book Greener Data, Volume III, launching on Earth Day 2026. The chapter shared EPG's philosophy on how modular construction reduces on-site waste, lowers embodied carbon, and enables
More news about: EPG Singapore Pte Ltd
Apr 19, 2026, 22:00 ET EPG veröffentlicht ersten ESG-Bericht und legt damit die Grundlage für eine nachhaltige globale Expansion
dass Modularbau der Weg ist, wie die Branche dieses Ziel erreichen kann."EPG ist stolz darauf, einen Beitrag zum Buch Greener Data, Volume III geleistet zu haben, das am Earth Day 2026 erscheint. In diesem Kapitel wird die Philosophie von EPG dargelegt, wie modulare Bauweise Abfall vor Ort
More news about: EPG Singapore Pte Ltd
Apr 17, 2026, 23:00 ET Gemini Space Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Gemini Space Station, Inc. - GEMI
platform; (ii) the Company had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, the Company's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that the
More news about: ClaimsFiler
Apr 17, 2026, 22:00 ET Apollo Global Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Apollo Global Management, Inc. - APO
regarding the Company's business; (ii) as a result, the Company's assertion that Apollo Global had never done business with Jeffrey Epstein was untrue; (iii) because of the entanglement between Apollo Global's leaders and Jeffrey Epstein, the harm to the Company's reputation was more than a mere possibility;
More news about: ClaimsFiler
Apr 17, 2026, 22:00 ET Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO
result, the administration of DCCR to treat hyperphagia in individuals with PWS posed materially greater safety risks than disclosed by the Company; and (iii) consequently, DCCR had materially lower commercial viability and undisclosed risks related to the likelihood of significant and widespread adverse events
More news about: ClaimsFiler
Apr 17, 2026, 20:29 ET Banistmo Announces Expiration and Results of its Consent Solicitation relating to its 4.250% Senior Notes due 2027
will not constitute a "Change of Control," (ii) provide that each of Bancolombia S.A., Grupo Cibest and ICC will be a "Permitted Holder," and (iii) add to, amend, supplement or change certain other defined terms contained in the Indenture and the Notes related to the foregoing (collectively, the
More news about: Banistmo, S.A.
Apr 17, 2026, 17:20 ET IsoEnergy Announces New At-The-Market Equity Program
Stock Exchange (the "TSX") that constitute "at-the-market distributions" as defined in National Instrument 44-102 – Shelf Distributions, (iii) on another Canadian "marketplace", as such term is defined in NI 21-101, upon which the Common Shares are listed, quoted or otherwise traded, or (iv)
More news about: IsoEnergy Ltd.
Apr 17, 2026, 16:15 ET UNITED BANCSHARES, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS AND $0.25 DIVIDEND
DirectorsRobert L. BenrothHerbert H. Huffman IIIDaniel W. Schutt, ChairmanR. Steven Unverferth
More news about: United Bancshares, Inc.